Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 5CNS 5Sarcoma 4Gastrointestinal 4Classical hematology 4Tumor-Agnostic 3Gynecologic 3Genitourinary 3Head & Neck 2Dermatologic 2Myeloid 1Endocrine 1

Conditions

Neoplasms 2Neoplasm Metastasis 1

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Radiotherapy 47Capecitabine 47Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Tranexamic Acid × Tumor-Agnostic × Clear all
NCT05053867 2026-01-14

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT06244498 2024-02-06

Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty

Podkarpackie Oncological Center

Completed
110 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01980355 2023-08-07

TXA

Corewell Health West

Phase NA Completed
76 enrolled 9 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡